Literature DB >> 6482652

Decreased defence against free radicals in rat heart during normal reperfusion after hypoxic, ischemic and calcium-free perfusion.

R H Julicher, L B Tijburg, L Sterrenberg, A Bast, J M Koomen, J Noordhoek.   

Abstract

Excessive formation of free radicals possibly plays an important role in the origin of irreversible damage of the heart after hypoxic, ischemic or Ca2+-free treatment. The effect of these treatments on the activity of superoxide dismutase and the glutathione system was studied on isolated rat heart. These activities reflect the protective capacity of the heart against reactive substances. In addition the peroxidation of lipids is determined in the treated hearts using malondialdehyde formation as an indicator. All experiments were performed using a Langendorff-apparatus with recirculating perfusion. The observed changes in the components of the glutathione system and superoxide dismutase activity both after hypoxic, ischemic and Ca2+-free perfusion, as measured upon reperfusion, indicate a decrease in cellular defense mechanisms in the heart against free radicals. The effect was most pronounced upon Ca2+-repletion after a period of Ca2+-free perfusion. No malondialdehyde could however be detected either in the tissue of the treated hearts or in the perfusate. Our data give reason to expect beneficial effects of an adequate pharmacological treatment, which replenishes the cellular defence systems.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6482652     DOI: 10.1016/0024-3205(84)90099-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  10 in total

1.  No evidence of oxygen free radicals-mediated damage during the calcium paradox.

Authors:  R Ferrari; C Ceconi; S Curello; A Cargnoni; T J Ruigrok
Journal:  Basic Res Cardiol       Date:  1989 Jul-Aug       Impact factor: 17.165

2.  Oxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused hearts.

Authors:  G Ambrosio; J T Flaherty; C Duilio; I Tritto; G Santoro; P P Elia; M Condorelli; M Chiariello
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

3.  Lipid peroxidation during myocardial reperfusion.

Authors:  C Ceconi; A Cargnoni; E Pasini; E Condorelli; S Currello; R Ferrari
Journal:  Mol Cell Biochem       Date:  1992-04       Impact factor: 3.396

4.  Red blood cell anti-oxidant parameters in silicosis.

Authors:  P J Borm; A Bast; E F Wouters; J J Slangen; G M Swaen; T de Boorder
Journal:  Int Arch Occup Environ Health       Date:  1986       Impact factor: 3.015

5.  Hydrogen peroxide generation by mitochondria isolated from regionally ischemic and nonischemic dog myocardium.

Authors:  M Shlafer; K P Gallagher; S Adkins
Journal:  Basic Res Cardiol       Date:  1990 Jul-Aug       Impact factor: 17.165

6.  Evaluation of free radical and lipid peroxide formation during global ischemia and reperfusion in isolated perfused rat heart.

Authors:  V Maupoil; L Rochette
Journal:  Cardiovasc Drugs Ther       Date:  1988-12       Impact factor: 3.727

7.  Lipid peroxidation and the levels of antioxidant enzymes in coronary artery disease.

Authors:  K Kaur; G Bedi; M Kaur; Anil Vij; Inderpreet Kaur
Journal:  Indian J Clin Biochem       Date:  2008-03-06

8.  Detection of ischemia-reperfusion cardiac injury by cardiac muscle chemiluminescence.

Authors:  K Prasad; P Lee; S V Mantha; J Kalra; M Prasad; J B Gupta
Journal:  Mol Cell Biochem       Date:  1992-09-22       Impact factor: 3.396

9.  Glutathione disulfide as an index of oxidative stress during postischemic reperfusion in isolated rat hearts.

Authors:  R J Verbunt; W G van Dockum; E M Bastiaanse; J M Egas; A van der Laarse
Journal:  Mol Cell Biochem       Date:  1995-03-09       Impact factor: 3.396

10.  No evidence of malonyldialdehyde formation during reoxygenation injury in vitamin E-deficient rat heart.

Authors:  C T Marchant; D M Barron; S M Wilson; L R Jordan; R J Willis
Journal:  Basic Res Cardiol       Date:  1993 Jul-Aug       Impact factor: 17.165

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.